Most Australian women using IVF pay for add-on treatments with ‘weak’ evidence behind them, research finds
By Joseph Dunstan,
ABC News
| 05. 03. 2021
Most women undergoing IVF treatment in Australia are paying for one or more add-on treatments, despite limited proof of their effectiveness, new research has found.
Key points:
- Researchers found 82 per cent of women paid for an add-on during IVF treatment
- Acupuncture, pre-implantation genetic testing and Chinese herbal medicine were the three most common treatments
- Lead author Sarah Lensen said the evidence base for many of the add-on treatments was weak
Researchers from Australia, the United Kingdom and the Victorian IVF regulator VARTA found 82 per cent of 1,590 women surveyed had used an additional treatment while undergoing IVF.
Lead author and University of Melbourne researcher Sarah Lensen said the most common add-on treatments identified in the survey were acupuncture, pre-implantation genetic testing of embryos for abnormal chromosomes and Chinese herbal medicine.
But Dr Lensen said the evidence base for the treatments was “rather weak.”
“None of the add-ons that they use in Australia are supported by high quality, robust evidence that they help people to have a baby from IVF and that they're safe to use,” she said.
“There is...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
